CTIS.eu › Cities › France › Nice
Nice
France
672 total trials
294 recruiting
2023-507130-24-00
5
2021-10-22
Neovascular age-related macular degeneration (nAMD)
2024-516651-41-00
5
2021-10-08
COPD : chronic obstructive Pulmonary disease
2023-510389-28-00
5
2021-06-14
short bowel syndrome
2023-509635-89-00
9
2021-06-01
DIPSS-Intermediate or High Risk Myelofibrosis
2023-507132-21-00
10
2021-05-11
Early Parkinson's disease
2023-504419-34-00
4
2021-04-29
Autoinflammatory diseases including NLRC4-Gain of Function (GOF) also
2023-509120-17-00
5
2021-04-12
Myelofibrosis
2024-514467-26-00
4
2021-04-07
Indolent Systemic Mastocytosis
2024-511658-28-01
5
2021-04-06
primary sclerosing cholangitis
2023-506962-30-00
5
2021-03-29
Non-alcoholic steatohepatitis (NASH)
2023-510006-40-00
5
2021-03-22
Myasthenia Gravis which is either due to acetylcholine receptor antibo
2023-507890-17-00
5
2021-02-22
Anemia associated with myeloproliferative neoplasm (MPN)-associated my
2024-513325-23-00
4
2021-02-03
Myelofibrosis
2024-514502-31-00
5
2021-01-11
Prurigo Nodularis
2022-501645-70-00
5
2020-11-25
Crohns Disease
2022-502611-10-00
5
2020-11-24
Primary Progressive Multiple Sclerosis (PPMS)
2023-507153-16-00
5
2020-11-18
Higher-Risk Myelodysplastic Syndrome
2023-503380-42-00
6
2020-11-16
patient with moderate to severe Crohn's disease
with at least one acti
2024-517536-22-00
7
2020-09-22
Unresectable or metastatic cutaneous squamous cell carcinoma
2024-516102-36-00
4
2020-07-29
Minimal Change Nephrotic Syndrom
2024-515669-32-00
5
2020-06-30
Pulmonary arterial hypertension
2023-510455-28-00
5
2020-06-10
Hypereosinophilic Syndrome (HES)
2024-511653-22-00
5
2020-02-12
Cutaneous Squamous Cell Carcinoma (CSCC)
2024-511940-20-00
5
2020-02-05
Parkinson's disease
Showing 481–504 of 672 trials